Odyssey Thera Signs Cell-Based Assay Services Agreement with Lexicon Genetics | GenomeWeb

NEW YORK, June 20 (GenomeWeb News) - Odyssey Thera has signed a services agreement with Lexicon Genetics under which it will characterize the pathway activity of certain Lexicon compounds in human cells.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.